In this study, we demonstrate that inhibition of CSF-1R signaling in vitro by either knocking out CSF-1R in macrophages, or adding a blocking antibody, decreased macrophage release of VEGF-A, as well as trans-endothelial migration of tumor cells, an in vitro measure of intravasation capability. This evidence concerns the gene VEGFA and neoplasm.